National Institutes of Health

National Institutes of Health

Signal active

Investment Firm

Overview

National Institutes of Health is a biomedical research facility in the United States. It is affiliated with the United States Department of Health and Human Services. It is the primary agency of the United States government responsible for biomedical and health-related research. It conducts its own scientific research through its Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.

National Institutes of Health has 1,200 principal investigators and more than 4,000 postdoctoral fellows in basic, translational, and clinical research. It comprises 27 separate institutes and centers that conduct research in different disciplines of biomedical science.

With scientific accomplishments such as the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, the creation of vaccines against hepatitis, Haemophilus influenzae (HIB), and human papillomavirus, National Institutes of Health has many agencies under its control.

National Institutes of Health was established in 1887. It is based in Bethesda, Maryland.

Highlights

Founded

1887

Industry

Biotechnology

Employees

10001+

Investment

889

Lead Investment

640

Exits

89

Stages

Seed, Early Stage Venture, Late Stage Venture

Investor Type

Entrepreneurship Program

Location

United States, North America

Contact Information

Social

Profile Resume

National Institutes of Health, established in 1887 and headquartered in United States, North America., specializes in Seed, Early Stage Venture, Late Stage Venture investments across Manufacturing, Transaction Processing, Product Design, Biotechnology, Medical, Health Diagnostics, Pharmaceutical, Biopharma, Big Data, Genetics. The organization boasts a portfolio of 882 investments, with an average round size of $9.3M and 89 successful exits. Their recent investments include PlastiPure, Akonni Biosystems, Selecta Biosciences, Maven Biotechnologies, Natera. The highest investment round they participated in was $71.0B. Among their most notable exits are PlastiPure and Akonni Biosystems. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Aaron Abend

Aaron Abend

AllofUs Advisory Panel Member

imagePlace Samuel Broder

Samuel Broder

Director

imagePlace Francis Collins

Francis Collins

Director

imagePlace Saifullah Shafiq

Saifullah Shafiq

SharePoint Consultant

imagePlace Avindra Nath

Avindra Nath

Clinical Director

imagePlace Anthony Fauci

Anthony Fauci

5th Director of the National Institute of Allergy and Infectious Diseases

Investment portfolio

National Institutes of Health has made 889 investments. Their most recent investment was on Jul 10, 2024, when Orlance raised $3.0M.

National Institutes of Health has made 199 diversity investments. Their most recent diversity investment was on Jul 22, 2024, when MaMome raised $300.0K.

investments

889

Diversity investments

199

Lead investments

640

Number of exits

89

Investments

889

Annouced DateOrganization NameIndustryMoney Raised
Jul 22, 2024
MaMome MaMome
Biotechnology300.0K
Jul 31, 2024
Cortechs.ai Cortechs.ai
Softwarenull
Aug 05, 2024--4.5M
Aug 05, 2024
University of Arkansas for Medical Sciences University of Arkansas for Medical Sciences
Health Carenull

Exits

89

Funding Timeline

Funding rounds

889

Investors

0

Funds

0

Funding Rounds

889

National Institutes of Health has raised 889 rounds. Their latest funding was raised on Aug 05, 2024 from a Grant - University of Arkansas for Medical Sciences round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jul 22, 2024
Grant - MaMome Grant - MaMome
-300.0K-
Jul 31, 2024
Grant - Cortechs.ai Grant - Cortechs.ai
-0-
Aug 05, 2024
Grant - Immunovia Grant - Immunovia
-4.5M-
Aug 05, 2024
Grant - University of Arkansas for Medical Sciences Grant - University of Arkansas for Medical Sciences
-0-

Investors

1

Investor NameLead InvestorFunding RoundMoney Raised
-No
Grant - National Institutes of Health
5.0M

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.